Combined targeting of pathways regulating synaptic formation and autophagy attenuates Alzheimer’s disease pathology in mice
All drug trials completed to date have fallen short of meeting the clinical endpoint of significantly slowing cognitive decline in Alzheimer’s disease (AD) patients. In this study, we repurposed two FDA-approved drugs, Fasudil and Lonafarnib, targeting synaptic formation (i.e., Wnt signaling) and ce...
Main Authors: | Christiana Bjorkli, Mary Hemler, Joshua B. Julian, Axel Sandvig, Ioanna Sandvig |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.913971/full |
Similar Items
-
Bridging the Gap Between Fluid Biomarkers for Alzheimer’s Disease, Model Systems, and Patients
by: Christiana Bjorkli, et al.
Published: (2020-09-01) -
Selective inhibition of excitatory synaptic transmission alters the emergent bursting dynamics of in vitro neural networks
by: Janelle Shari Weir, et al.
Published: (2023-02-01) -
Editorial: Criticality in neural network behavior and its implications for computational processing in healthy and perturbed conditions
by: Ioanna Sandvig, et al.
Published: (2022-10-01) -
Connectomics of Morphogenetically Engineered Neurons as a Predictor of Functional Integration in the Ischemic Brain
by: Axel Sandvig, et al.
Published: (2019-06-01) -
Neuronal avalanche dynamics and functional connectivity elucidate information propagation in vitro
by: Kristine Heiney, et al.
Published: (2022-09-01)